Xconomy
SEPTEMBER 9, 2016
The company announced this week that it has developed a similar testing service for screening pre-clinical drug candidates on living human kidney tissue. Organovo said it also is collaborating on scientific studies of its kidney tissue technology as part of a continuing early access program that includes two big pharma companies. “We
socalTECH
JANUARY 20, 2011
Freebinar gives them a solution that includes screen sharing, voice over IP audio, broadcast, conference calling, and allow you to meet with as many as 150 people at the same time. What we've been able to do, is non-intrusively serve ads on the right side of the screen, which rotate every 60 seconds.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
socalTECH
AUGUST 2, 2017
Our first product is called Seed, which is a screening test for male infertility. We have done both retrospective proof-of-concept and also prospective studies to prove out the concept, which is based on probably 100 papers worth of articles published in scientific journals. There's a lot of foundational science here.
Xconomy
JUNE 10, 2016
The results give the company confidence it can expand its tests to screen for early cancer in high-risk people who are otherwise healthy. —At the annual BIO conference, which gathered in San Francisco for the first time since cops battled street protesters in 2004, industry bigwigs took to the stage to defend themselves. .
socalTECH
OCTOBER 19, 2016
It's all about the app, or the computer screen, or the data. Lee and I were recently at the Exponential Conference, and Lee got up in front of the whole group, primarily healthcare providers. In 2014, we did an IRB approved study when I was doing this for 30 to 40 percent of my time, where I learned three things. READ MORE>>.
SoCal CTO
JUNE 9, 2010
Draw Your Ideas - A VC : Venture Capital and Technology , May 16, 2010 I saw Jack Dorsey give this talk at The 99% Conference last month. saw Jack Dorsey give this talk at The 99% Conference last month. Of the ones I have been to recently, the Nantucket Conference has been my favorite. It's a great talk. It's a great talk.
Xconomy
JUNE 17, 2016
Data from a hematology conference stoked dreams of approval, though still on a far horizon, for a couple drug makers. Preventative Services Task Force changed its classification of colorectal cancer screening methods, which has implications for Exact’s diagnostic, Cologuard. You think a Game 7 in the NBA Finals is going to be epic?
Expert insights. Personalized for you.
40 
Let's personalize your content